12/14 PHARMACY LIMITED
No material changes in the last 30 days.
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 80/100 (exceptional), bankability 67/100. Strong seller-intent signal (63/100, director aged 71). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Consolidate lender relationships. 5 distinct lenders creates friction — refinance into single-lender structure for cleaner diligence. Most likely exit: strategic trade sale (88/100).
Refinance opportunity
6 live charges · 5 lenders · oldest 23.6y
Refinance viable after a tidy-up — address the highlighted items first.
- · Oldest live charge is 23.6 years old — likely at or near maturity.
- · 5 lenders named — inter-creditor friction likely.
- · Legal-friction score 25/100 — workable, but lender will want more DD.
- · Profitable and stable/growing — lender coverage supportable.
Data confidence
Overall: medium (73/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Sector-multiple EBITDA, turnover, and NAV-proxy valuation range with confidence tier — derived from extracted iXBRL financials.
Available from the Pro tier upwards.
See pricing →Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · FRS 102| Metric | 2023-12-31 |
|---|---|
| Profit before tax | £372.7k |
| Average employees | 2000 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
4 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (40 events)Click to expand
- 2025-09-09📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2025-06-09📄accounts-with-accounts-type-fullaccounts · AA
- 2025-05-14📄gazette-filings-brought-up-to-dategazette · DISS40
- 2025-05-13📄gazette-notice-compulsorygazette · GAZ1
- 2024-12-14📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2024-09-26📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2024-03-19📄change-person-director-company-with-change-dateofficers · CH01
- 2023-12-11📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-10-04📄mortgage-create-with-deed-with-charge-number-charge-creation-datemortgage · MR01
- 2023-10-03🔒Charge registered #6Lender: Rx Bridge Limited
- 2023-06-09📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2022-12-21📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-09-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-11-12📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-09-30📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-09-12📄mortgage-create-with-deed-with-charge-number-charge-creation-datemortgage · MR01
- 2019-09-10🔒Charge registered #5Lender: Hsbc UK Bank PLC
- 2019-04-25📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2019-04-25📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2018-08-08🔓Charge satisfied #4
- 2018-08-08🔓Charge satisfied #3
- 2012-01-01➕WALJI, Safil appointeddirector
- 2011-08-24🔓Charge satisfied #2
- 2011-08-24🔓Charge satisfied #1
- 2011-07-25🔒Charge registered #4Lender: National Westminster Bank PLC
- 2011-07-25🔒Charge registered #3Lender: National Westminster Bank PLC
- 2011-05-09➖NANJI, Mohamed Sherali Walji resigneddirector
- 2005-04-01➕WALJI, Safil appointeddirector
- 2005-04-01➖WALJI, Safil resigneddirector
- 2002-12-01🔒Charge registered #2Lender: Aah Pharmaceuticals Limited, Barclay Pharmaceuticals Limited and Farillon Limited
- 2002-11-16🔒Charge registered #1Lender: Barclays Bank PLC
- 2002-04-15🏢Company incorporatedAs 12/14 PHARMACY LIMITED
- 2002-04-15➕DAMANI, Zainab Pyarali appointedsecretary
- 2002-04-15➕DAMANI, Zainab Pyarali appointeddirector
- 2002-04-15➕JESSA, Mohamed Jaffer appointeddirector
- 2002-04-15➕TEMPLE SECRETARIES LIMITED appointedcorporate-nominee-secretary
- 2002-04-15➖TEMPLE SECRETARIES LIMITED resignedcorporate-nominee-secretary
- 2002-04-15➕NANJI, Mohamed Sherali Walji appointeddirector
- 2002-04-15➕COMPANY DIRECTORS LIMITED appointedcorporate-nominee-director
- 2002-04-15➖COMPANY DIRECTORS LIMITED resignedcorporate-nominee-director
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Long-tenure founder: Senior director has been in place 24 years — deep operational knowledge concentrated in one person.
- +Founder age: Director aged approximately 71 — succession pressure is live.
Succession & seller-readiness
Strong acquirability signals converging. Worth approaching directly — this is how off-market deals start.
- primaryFounder aged 70+: Senior director is approximately 71 years old. Natural succession window is now.
- primary20+ year tenure: Director in role 24 years. Very long tenure is a classic succession signal.
- secondaryStable-but-static management: Company is 24 years old and no new directors in the last 3 years — succession not yet being planned internally.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
1 med ·Multiple instances where a charge was satisfied and a new charge created within 6 months. Suggests active refinancing cycle.
Group structure
Sakina Health Care Ltd is the ultimate parent — holding 75%+ shares. This company sits inside their group.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Sakina Health Care Ltd Corporate entity | 75–100% | — | 75-100% shares | 06/04/2016 |
1 historic (ceased) PSC
- Mr Safil Waljiceased 15/04/2019· significant influence
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · PE postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A NAZERALI CO LTD→ 14699845 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ALALI HEALTHCARE LTD→ 16065674 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ALBERT VINCENT GROUP LIMITED→ 06624634 · est 2008 · no financials extracted | — | — | — | — | 17y | — | — |
| ALCONBURY AND BRAMPTON INNOVATIVE HEALTHCARE LTD→ 13435019 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ALL ASPECTS AGENCY LIMITED→ 12340633 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ALL BRIDGES LIMITED→ 06980458 · est 2009 · no financials extracted | — | — | — | — | 16y | — | — |
| ALL SEASONS CHILDRENS PLAY CIC→ 14027912 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ALLIED HEALTH SOUTH LINCOLNSHIRE LTD→ 10070357 · est 2016 · no financials extracted | — | — | — | — | 10y | — | — |
| ALNA-HEALTH LTD→ 15014930 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMA SMILES LTD→ 15072454 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMAKS MEDICAL SERVICES & SUPPLIERS LTD→ 11619032 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AMAN & RAYYAN LTD→ 09869331 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (4 active · 4 resigned)
Click a director name to see their full track record across all companies.
Mortgages & charges
| Type | Properties | |||||
|---|---|---|---|---|---|---|
| outstanding | Rx Bridge Rx Bridge Limited | A registered charge | 3 properties | 03/10/2023 | — | |
| outstanding | HSBC Hsbc UK Bank PLC | A registered charge | 1 property | 10/09/2019 | — | |
| satisfied | National Westminster Bank National Westminster Bank PLC | Debenture | 1 property | 25/07/2011 | 08/08/2018 | |
| satisfied | National Westminster Bank National Westminster Bank PLC | Legal charge | 1 property | 25/07/2011 | 08/08/2018 | |
| satisfied | Aah Pharmaceuticals , Barclay Pharmaceuticals and Farillon Aah Pharmaceuticals Limited, Barclay Pharmaceuticals Limited and Farillon Limited | Debenture | 1 property | 01/12/2002 | 24/08/2011 | |
| satisfied | Barclays Barclays Bank PLC | Debenture | 1 property | 16/11/2002 | 24/08/2011 |